Accumulating evidence has demonstrated that serum Chi3l1 levels tend to increase with the progression of liver fibrosis; thus, Chi3l1 is a noninvasive serum biomarker for diagnosing and staging liver fibrosis [75,76]. Here, CHI3L1 is linked to Hepatic fibrosis.